Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye ... glaucoma. Other developments in the ophthalmic sector this year included the Alcon ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

There are new treatments to help patients with glaucoma, and they’re just in time. The disease is the second leading cause of ...

Managing uveitic glaucoma presents a significant challenge for eye care providers. When medical therapy fails, surgical intervention is often required. Researchers of this retrospective study ...

The global vision care products market is projected to reach USD 103.7 billion by 2032, growing at a CAGR of 6.21%. This growth ...

The American Glaucoma Society and American Academy of Ophthalmology are warning eye doctors to be aware of potentially toxic ...

Early detection and monitoring are key to the diagnosis and management of ocular diseases, including glaucoma, retinal and ...

Fort Worth, Texas-based Alcon Laboratories has voluntarily recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, which are packaged in batches of 25.

Glaucoma is a common eye condition that can affect people as they age, especially those over 60. It damages the optic nerve, ...

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...